Aims of this study were to investigate the prevalence of metabolic syndrome (MS), diagnosed according to the International Diabetes Federation (IDF) criteria and its relationship with echocardiographic parameters of cardiac structure and function. The study was performed in 707 subjects, age 45-54 years, of the Gubbio Population Study who underwent a comprehensive examination including measurement of body size, blood pressure (BP) and heart rate, 12-lead electrocardiogram, Doppler echocardiography, standardized blood and urine laboratory tests. One hundred and fifty-three subjects were found to have MS, which was more frequent among hypertensive patients than normotensive controls (36.2 vs 13.7%, Po0.001). Apart from visceral obesity present in all subjects by definition according to the IDF criteria, high levels of BP (4130/85 mm Hg) and triglycerides (X150 mg/dl) were the most frequently observed components of the syndrome, since their prevalence averaged 75% of those with the syndrome. Left ventricular mass (95.6722 vs 86.4722 g/m 2 ; Po0.001) and prevalence of left ventricular hypertrophy were increased in the subgroup with MS. Waist circumference, BP and blood glucose were the components of the syndrome with stronger impact on cardiac mass. An early impairment of the diastolic function was detected in this subgroup with a reduction of the early-to-late diastolic filling (0.9170.17 vs 0.9970.23, Po0.001). The results of the present study indicate that MS is frequent in middleaged general population, particularly in subjects with arterial hypertension. The syndrome is associated to the increase in ventricular mass and the early impairment of diastolic function.
Introduction
The recent guidelines for treatment of arterial hypertension underline the relevance of assessing total cardiovascular risk and point out that each patient whose blood pressure (BP) is still within the high-normal range may be in need of antihypertensive drugs if his overall risk is high. 1 In this regard the metabolic syndrome (MS), which is marked by the association of several atherogenic factors, has been shown to confer an increased risk of fatal and non-fatal cardiovascular events. 2 The syndrome occurs with different prevalence depending on age and sex of the subjects, as well as on source of the sample, namely if it comes from a general population or from an outpatient clinic.
The present study refers to a subgroup of the larger Gubbio Population Study and aimed at investigating (a) the prevalence of the MS, diagnosed according to the criteria of the International Diabetes Federation (IDF); 3 (b) the role of each individual component of the MS in its prevalence; (c) the association of the MS with initial alterations in cardiac structure and function, as indicated by an increase in cardiac mass and a decreased left ventricular compliance.
Patients and methods

Study population
The Gubbio Population Study is a clinical survey performed in the small town of Gubbio, in central Italy, not too far from Perugia. The study started in 1983-1985 when 5376 men and women, aged 5-90 years were first examined; subsequently, they underwent a follow-up examination in 1989-1992. [4] [5] The entire population living within the area bounded by the medieval walls of the town was invited to participate in the study. A majority of them (n ¼ 3536 of the 3836 who had been invited) accepted the invitation and others (n ¼ 1840), residing outside the walls, were evaluated at the request of the health administration. In both surveys, the comprehensive examination included measurement of body weight, height, waist-to-hip ratio, subscapular and triceps skinfold thicknesses, BP and heart rate (HR), a 12-lead electrocardiogram, standardized blood and urine laboratory tests, individual and family medical history and questionnaires on lifestyle and awareness of hypertension and other cardiovascular risk factors. 4 Fat mass and fat-free mass were calculated from the logarithm of the sum of the thickness of two skinfolds (subscapular þ triceps), according to published equations. 6 BP was measured by doctors trained by the Istituto Superiore di Sanità, Rome. Measurements were taken after the participant had been seated quietly for 5 min; pressure was measured on the right arm, with the use of a cuff of appropriate size. Three recordings were made, 1 min apart. The first and the fifth phases of Korotkoff sounds were defined as systolic and diastolic pressures, respectively. 4 At the second survey, all persons in the age range 45-54 years (n ¼ 831) were invited for an echocardiographic examination and 739 (87.9%) accepted to participate. The present analysis included 707 subjects whose echocardiographic study was considered of high level for the evaluation of the parameters.
Subjects who entered the study were divided in two subgroups -those with and those without MSaccording to the IDF criteria. 3 MS, therefore, included patients with waist circumference 494 cm for men and 480 for women plus at least two of the following: FBGX100 mg/dl (5.6 millimoles/l), HDL-cholesterol o40 mg/dl (1.04 millimoles/l) for men and o50 mg/dl (1.30 millimoles/l) for women, total triglycerides (Tg)X150 mg/dl (1.69 millimoles/ l), systolic BP4130 or diastolic BP485 mm Hg or use of antihypertensive treatment. The protocol of the study had been approved by the local Ethics Committee and informed consent was obtained by all participants in the study.
Laboratory analyses
Serum cholesterol, HDL-chol, total Tg and blood glucose were measured according to the methods fully described elsewhere. 4 
Echocardiographic procedures
All echocardiograms were performed in 1990-1992 by the same echocardiographer (OC). Echocardiograms were obtained with participants lying in the left lateral decubitus position with the head at 301 from the horizontal. A Vingmed 700 Echocardiographic machine with a 3. A second set of measurements was also taken according to the Penn convention criteria to calculate left ventricular mass (LVM). 8 LVM was indexed to body surface area (BSA), which we have shown to be a particularly useful indexation to detect BP-related left ventricular hypertrophy (LVH) 9 and to height to the power of 2.7, which has been shown to detect also obesity related LVH. LVH was defined as LVM/height 2.7 X49.2 g/m 2.7 for men and X46.7 g/m 2.7 for women.
10
All echocardiograms were read by the same operator (OC) and in a 20% sample of tracings, randomly chosen, intra-reader variability of the measurement was evaluated. The two measurements of each variable were closely related to each other (Po0.001) since the % error was 3.76 for IVST, 4.28 for PWT and 1.06 for LVM.
11
Pulsed Doppler echocardiography After M-mode recordings, pulsed Doppler echocardiography was performed. Transmitral flow velocity waveforms were obtained from the apex in the fourand five-chamber projection with the sample volume placed at the level of the mitral annulus and at the tip of the mitral valve leaflets. The angle between the Doppler beam and the assumed direction of the transmitral flow was less than 101 in all subjects. The peak of the early diastolic velocity (E) and the late diastolic wave (A) were measured in m/s and their ratio (E/A) was determined. The flow velocity-time integral of early diastolic flow (Ei), that of late diastolic flow (Ai) were also calculated. 12 Statistical analyses Data were analysed by using SPSS (SPSS-PC; SPSS Inc., Chicago, Illinois, USA) statistical package. Results were expressed as mean7standard deviations (M7s.d.) or 95% confidence intervals (95% CI) as indicated. Comparisons of means were performed by unpaired t-test and by one-way analysis of variance with Tukey's multiple comparisons. Pearson linear correlation was used to detect bivariate associations between different variables. Difference between categorical variables was assessed by w 2 -test. Multiple linear regression was used to determine the role of the different components of the MS as independent predictors of LVM and diastolic function (E/A) allowing for potential confounders.
Results
Our study population included 707 subjects, 457 normotensive subjects (168 male, 289 female) and 250 hypertensive subjects (101 men, 149 female).
Overall 153 subjects (21.6% of the study population) were found to have MS. Prevalence was higher in men (23.8%) than in women (16.6%), but this difference did not reach statistical significance. The syndrome was significantly more frequent among hypertensive patients (91/250, 36.4% of the sample) than among normotensive controls (62/457, 13.7%), Po0.001. Prevalence of abnormal waist circumference, high Tg, low HDL-chol, high FBG and high BP levels, according to the cut-off accepted by the IDF, is shown in Figure 1 , left side. We have also evaluated the prevalence of obesity (BMI430 kg/m 2 ), hypertriglyceridemia (Tg4200 mg/dl), low HDLchol (o35 mg/dl for men and o45 mg/dl for women), diabetes (FBG4126 mg/dl) and hypertension (BP4140/90 mm Hg) as shown in Figure 1 , (right side). Prevalence of each of these alterations was significantly higher in the MS þ than in the MSÀ group.
Groups with and without MS were significantly different for body weight and body composition, systolic and diastolic BPs and all metabolic variables, except LDL-chol (Table 1) .
Echocardiographic parameters of left ventricular structure and systolic function significantly differed among subgroups (Table 2 ). In particular subjects with MS had a greater LVM and, accordingly, a higher prevalence of LVH (83/153 subjects with MS, 54.2% vs 141/554 subjects without MS, 25.4%; Po0.001). Regarding the geometrical pattern of the left ventricle, concentric hypertrophy was present in 5.0% of the MSÀ and in 8.5% of the MS þ group, eccentric hypertrophy in 20.4 and 45.7% respectively. Moreover 8.3% of MSÀ subjects and 4.4% of MS þ had concentric remodelling. The differences in the prevalence of the geometrical patterns of the left ventricle between subjects with and without MS were statistically significant (Po0.001). To evaluate further the influence of MS on LVM, multiple linear regression analysis was performed by setting multiple linear regression equations having LVM as independent variable. High FBG, high BP, high waist circumference, low HDL-chol and high Tg were introduced as independent variables with age and sex as covariates. The result of this analysis is shown in Table 3 . The analysis was, thereafter, repeated in each sex to evaluate whether there were differences in the strength of associations between parameters of the MS and LVM for men compared with women (Table 4) .
A significant difference was also observed in the parameters of diastolic function. In particular, subjects with MS had a nonsignificant reduction in the early component of the ventricular filling and a more marked, significant increase in the ventricular filling dependent on the atrial contraction; the ratio between the two components was, therefore, significantly higher in subjects of the MSÀ in comparison to the MS þ group after control for sex, age and HR (Table 5 ). The components of the MS explained about 10% of the E/A variability but only high BP (Po0.002) and visceral obesity were independently associated to E/A. Moreover, after adjustment for sex and age, LVIDd (F ¼ 6.64; Po0.01) but not LVM (F ¼ 1.60; n.s.) significantly affected E/A.
Discussion
MS is a clinical condition, which has been found associated to increased risk of cardiovascular diseases. Recently, the third report of the NCEP ATP III defined this syndrome as the concomitant presence of at least three of a group of variables. 13 These criteria were more recently confirmed with only minor changes by the statement of the American Heart Association (AHA)/National Heart Lung and Blood Institute (NHLBI).
14 The IDF, on the other hand, gave more importance to visceral adiposity and stated that the diagnosis of MS could be made only in the presence of high waist circumference associated with other two of the ATP III criteria.
The present study has investigated in a welldefined general population, in the age range 45-54 years, the prevalence of the MS and that of its contributors, as well as the relationship with noninvasively measured markers of cardiac involvement. Main limitation of the present findings is the cross-sectional design of the study, which does not allow to address whether the development of LVH is influenced by the disorders included in the diagnosis of MS but only gives information regarding the association between the syndrome and LVM or LVH. The syndrome was found to have a considerable prevalence in a middle-aged general population, averaging 22% of all subjects in the age range 45-54 years, with some greater prevalence among men, but was particularly frequent in the hypertensive subgroup (39 vs 9.2% in the normotensive one). This prevalence is similar to that found in US adults. 15 Regarding the factors entering the MS, apart from visceral adiposity present by definition in 100% of cases, high Tg, high BP and low HDL-chol values were the most frequently detected. However, when considering the corresponding disorders, hypertension was present in 70% of the sample and obesity hypertriglyceridaemia and low HDL-chol did not exceed the 50% prevalence. This is in agreement with previous observations indicating that hypertension and obesity, particularly increased visceral adipose tissue, are strongly associated with MS in both men and women. [16] [17] Non-invasively determined parameters of cardiac damage were significantly worse in subjects who were affected by the syndrome. LVM normalized for both BSA and height to the power of 2.7, as well as PWT and septum thickness, was significantly increased in the subgroup with MS. Accordingly the prevalence of ventricular hypertrophy, which is a well-defined predictor of early onset of coronary artery diseases, [18] [19] was significantly higher in the MS þ group. This observation is in agreement with previous studies in hypertensive and in normotensive subjects with signs of insulin resistance. [20] [21] [22] The present study also showed that of the five components of the MS body size and BP were particularly associated with LVM but also blood glucose was independently related to cardiac dimensions.
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We have, moreover, detected in our MS þ subgroup an early alteration of the diastolic filling of the left ventricle with a significant increase in the filling component owing to the atrial contraction and a corresponding nonsignificant reduction in the velocity of the early diastolic filling. These changes resulted in a significant reduction in their ratio. These results are in agreement with our previous findings in a normoglycemic, never-treated hypertensive population in which the E/A ratio decreased with the increase in insulin resistance, assessed as higher homeostasis metabolic assessment. 23 The present finding, however, deserves some consideration since subjects in the group MS þ have higher HR which may influence the lower E/A we observed and moreover, high BP and visceral obesity but not MS per se were found to be independently associated to E/A ratio. The observation of an early dysfunction of the diastolic ventricular filling is, however, one of the first findings of such abnormality in subjects with MS observed in a population sample, confirming data detected in the American Indian population. 24 In patients from the Hypertension Outpatient Clinic, the corresponding data are, however, conflicting since differences in diastolic function between subjects with and without MS were present in a study 25 and absent in another, 22 possibly because differences were obscured by the equally elevated BP values in both groups. Regarding the possible phenomenon of the pseudo-normalization of the E/A ratio, which occurs in subjects with particularly deteriorated diastolic function, it does not appear to influence the results of the present study since it should have played against our observation of a reduced E/A. The relationship of E/A with left ventricular diastolic diameter, however, supports the hypothesis that studies including patients with an advanced ventricular dilatation might suffer from this problem, which might prevent from the detection of the early impairment of the diastolic filling phase. Despite LVM is frequently increased in subjects with arterial hypertension and also in subjects with obesity, the present study is one of the few Table 4 Age-adjusted multiple regression analysis by sex (dependent variable: LVM, expressed in g (mean and 95% confidence intervals)) investigations, along with the report of the Strong Heart Study 24 and that of the ARIC Study in blacks, 26 showing in a general population that subjects with MS have increased prevalence of LVH. Moreover, we have also shown that not only BP and body weight are independently associated with the development of LVH but also FBG is significantly and independently related to LVM. Because of the concomitant presence of increased ventricular mass and altered diastolic function these subjects are, therefore, prone to heart failure which might be, at least in part, responsible for the poor outcome of the disease.
Perspectives
The results of the present study indicate that MS is frequently observed in general population, not only in patients with arterial hypertension but also in normotensive subjects. These patients have an increased LVM and consequently, show a higher prevalence of LVH. An impairment of the earlyto-atrial diastolic filling of the left ventricle was observed, as well. These observations are of clinical relevance since it is well known that the presence of LVH is associated to an increased risk of coronary events in hypertensive patients. 18 The need of an echographic study in these patients is supported by several considerations: (1) previous investigation regarding the comparison between echocardiography and electrocardiography in the diagnosis of LVH showed that in populations with high prevalence of LVH, as patients with MS are, the former costs less for cases detected and gives a better prognosis of morbid events; 27 (2) Cuspidi et al. 28 showed that ultrasound assessment not only of the heart but also of the carotid wall gives a more valid evaluation of the global cardiovascular risk in hypertensive patients without evidence of target organ damage; (3) patients with reduction of E on A, which is a predictor of the ventricular diastolic failure, are exposed to an increased risk of all-cause and cardiac mortality. 29 In addition, the present study has relevant implications also from the clinical research point of view. In particular, it will be interesting to compare the efficacy of pharmacological and nonpharmacological treatment or, probably better, of the combination of the two on the regression of LVH, particularly in patients with MS and high normal BP levels. What is known about this topic K Prevalence of metabolic syndrome in general population, according to the ATP criteria is rather high. K In Pima Indians and in blacks prevalence of LVH was found increased in subjects with MS in comparison with those without the syndrome. K In particular, in general population (Pima Indians) diastolic function has been found altered in subjects with MS. Data in patients from outpatient clinics are, however, conflicting.
What this study adds K Prevalence of metabolic syndrome, according to IDF criteria, in general population. K Prevalence of LVH is rather high in MS+ in comparison to MSÀ patients also in a Caucasian general population. K Increase in LVM is related not only to blood pressure and body weight but also to blood glucose; altered diastolic function was related to blood pressure and visceral obesity but not to left ventricular mass and MS per se.
